BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

633 related articles for article (PubMed ID: 25030467)

  • 1. Survival for haematological malignancies in Europe between 1997 and 2008 by region and age: results of EUROCARE-5, a population-based study.
    Sant M; Minicozzi P; Mounier M; Anderson LA; Brenner H; Holleczek B; Marcos-Gragera R; Maynadié M; Monnereau A; Osca-Gelis G; Visser O; De Angelis R;
    Lancet Oncol; 2014 Aug; 15(9):931-42. PubMed ID: 25030467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in dynamics of excess mortality rates and net survival after diagnosis of follicular lymphoma or diffuse large B-cell lymphoma: comparison between European population-based data (EUROCARE-5).
    Mounier M; Bossard N; Remontet L; Belot A; Minicozzi P; De Angelis R; Capocaccia R; Iwaz J; Monnereau A; Troussard X; Sant M; Maynadié M; Giorgi R; ;
    Lancet Haematol; 2015 Nov; 2(11):e481-91. PubMed ID: 26686258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Childhood cancer survival in Europe 1999-2007: results of EUROCARE-5--a population-based study.
    Gatta G; Botta L; Rossi S; Aareleid T; Bielska-Lasota M; Clavel J; Dimitrova N; Jakab Z; Kaatsch P; Lacour B; Mallone S; Marcos-Gragera R; Minicozzi P; Sánchez-Pérez MJ; Sant M; Santaquilani M; Stiller C; Tavilla A; Trama A; Visser O; Peris-Bonet R;
    Lancet Oncol; 2014 Jan; 15(1):35-47. PubMed ID: 24314616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
    ; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
    Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent cancer survival in Europe: a 2000-02 period analysis of EUROCARE-4 data.
    Verdecchia A; Francisci S; Brenner H; Gatta G; Micheli A; Mangone L; Kunkler I;
    Lancet Oncol; 2007 Sep; 8(9):784-96. PubMed ID: 17714993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival variations by country and age for lymphoid and myeloid malignancies in Europe 2000-2007: Results of EUROCARE-5 population-based study.
    De Angelis R; Minicozzi P; Sant M; Dal Maso L; Brewster DH; Osca-Gelis G; Visser O; Maynadié M; Marcos-Gragera R; Troussard X; Agius D; Roazzi P; Meneghini E; Monnereau A;
    Eur J Cancer; 2015 Oct; 51(15):2254-2268. PubMed ID: 26421827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variation in survival of adult patients with haematological malignancies in Europe since 1978. EUROCARE Working Group.
    Carli PM; Coebergh JW; Verdecchia A
    Eur J Cancer; 1998 Dec; 34(14 Spec No):2253-63. PubMed ID: 10070296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term survival for lymphoid neoplasms and national health expenditure (EUROCARE-6): a retrospective, population-based study.
    Sant M; Vener C; Lillini R; Rossi S; Bonfarnuzzo S; Marcos-Gragera R; Maynadié M; Innos K; Paapsi K; Visser O; Bernasconi A; Demuru E; Di Benedetto C; Mousavi SM; Blum M; Went P; Serraino D; Bennett D; Sánchez MJ; De Angelis R;
    Lancet Oncol; 2024 Jun; 25(6):731-743. PubMed ID: 38703784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE--5-a population-based study.
    De Angelis R; Sant M; Coleman MP; Francisci S; Baili P; Pierannunzio D; Trama A; Visser O; Brenner H; Ardanaz E; Bielska-Lasota M; Engholm G; Nennecke A; Siesling S; Berrino F; Capocaccia R;
    Lancet Oncol; 2014 Jan; 15(1):23-34. PubMed ID: 24314615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival for eight major cancers and all cancers combined for European adults diagnosed in 1995-99: results of the EUROCARE-4 study.
    Berrino F; De Angelis R; Sant M; Rosso S; Bielska-Lasota M; Coebergh JW; Santaquilani M;
    Lancet Oncol; 2007 Sep; 8(9):773-83. PubMed ID: 17714991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trends in the survival of patients diagnosed with malignant neoplasms of lymphoid, haematopoietic, and related tissue in the Nordic countries 1964-2003 followed up to the end of 2006.
    Storm HH; Klint A; Tryggvadóttir L; Gislum M; Engholm G; Bray F; Hakulinen T
    Acta Oncol; 2010 Jun; 49(5):694-712. PubMed ID: 20491526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An experience with sixty cases of haematological malignancies; a clinico haematological correlation.
    Idris M; Shah SH; Fareed J; Gul N
    J Ayub Med Coll Abbottabad; 2004; 16(4):51-4. PubMed ID: 15762065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Worldwide comparison of survival from childhood leukaemia for 1995-2009, by subtype, age, and sex (CONCORD-2): a population-based study of individual data for 89 828 children from 198 registries in 53 countries.
    Bonaventure A; Harewood R; Stiller CA; Gatta G; Clavel J; Stefan DC; Carreira H; Spika D; Marcos-Gragera R; Peris-Bonet R; Piñeros M; Sant M; Kuehni CE; Murphy MFG; Coleman MP; Allemani C;
    Lancet Haematol; 2017 May; 4(5):e202-e217. PubMed ID: 28411119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allogeneic transplant outcomes are not affected by body mass index (BMI) in patients with haematological malignancies.
    Nikolousis E; Nagra S; Paneesha S; Delgado J; Holder K; Bratby L; Chaganti S; Lovell R; Milligan D
    Ann Hematol; 2010 Nov; 89(11):1141-5. PubMed ID: 20544351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer survival in five continents: a worldwide population-based study (CONCORD).
    Coleman MP; Quaresma M; Berrino F; Lutz JM; De Angelis R; Capocaccia R; Baili P; Rachet B; Gatta G; Hakulinen T; Micheli A; Sant M; Weir HK; Elwood JM; Tsukuma H; Koifman S; E Silva GA; Francisci S; Santaquilani M; Verdecchia A; Storm HH; Young JL;
    Lancet Oncol; 2008 Aug; 9(8):730-56. PubMed ID: 18639491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends in 5- and 10-year survival after diagnosis with childhood hematologic malignancies in the United States, 1990-2004.
    Pulte D; Gondos A; Brenner H
    J Natl Cancer Inst; 2008 Sep; 100(18):1301-9. PubMed ID: 18780868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Haematological malignancies: incidence in Basse-Normandie, France, for 1997-2004].
    Troussard X; Duchenet V; Cornet E; Mouchel D; Malet M; Collignon A
    Rev Epidemiol Sante Publique; 2009 Jun; 57(3):151-8. PubMed ID: 19375876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival of European adolescents and young adults diagnosed with cancer in 2000-07: population-based data from EUROCARE-5.
    Trama A; Botta L; Foschi R; Ferrari A; Stiller C; Desandes E; Maule MM; Merletti F; Gatta G;
    Lancet Oncol; 2016 Jul; 17(7):896-906. PubMed ID: 27237614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is low survival for cancer in Eastern Europe due principally to late stage at diagnosis?
    Minicozzi P; Walsh PM; Sánchez MJ; Trama A; Innos K; Marcos-Gragera R; Dimitrova N; Botta L; Johannesen TB; Rossi S; Sant M;
    Eur J Cancer; 2018 Apr; 93():127-137. PubMed ID: 29518726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Incidence of haematological malignancies in adults in Szabolcs-Szatmár-Bereg county, Hungary, between 1983 and 2012. Analysis of data from a thirty-year period].
    Jakó J; Szerafin L; Nagy P
    Orv Hetil; 2013 Nov; 154(47):1858-64. PubMed ID: 24240522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.